201 related articles for article (PubMed ID: 17244154)
1. Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes.
Luopajärvi K; Skarsvik S; Ilonen J; Akerblom HK; Vaarala O
Immunology; 2007 Jun; 121(2):189-96. PubMed ID: 17244154
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
[TBL] [Abstract][Full Text] [Related]
4. Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.
Skarsvik S; Ludvigsson J; Vaarala O
Immunology; 2005 Feb; 114(2):287-93. PubMed ID: 15667574
[TBL] [Abstract][Full Text] [Related]
5. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children.
Walldén J; Ilonen J; Roivainen M; Ludvigsson J; Vaarala O;
Scand J Immunol; 2008 Sep; 68(3):345-50. PubMed ID: 18782261
[TBL] [Abstract][Full Text] [Related]
6. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
[TBL] [Abstract][Full Text] [Related]
7. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
[TBL] [Abstract][Full Text] [Related]
8. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia.
Peet A; Kool P; Ilonen J; Knip M; Tillmann V;
Diabetes Metab Res Rev; 2012 Jul; 28(5):455-61. PubMed ID: 22492720
[TBL] [Abstract][Full Text] [Related]
9. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children.
Jonson CO; Lernmark A; Ludvigsson J; Rutledge EA; Hinkkanen A; Faresjö M
Pediatr Diabetes; 2007 Aug; 8(4):185-92. PubMed ID: 17659059
[TBL] [Abstract][Full Text] [Related]
10. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
[TBL] [Abstract][Full Text] [Related]
11. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
[TBL] [Abstract][Full Text] [Related]
12. Frequency of MICA in all babies in southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes.
Gupta M; Ludvigsson J; Sanjeevi CB
Ann N Y Acad Sci; 2004 Dec; 1037():138-44. PubMed ID: 15699508
[TBL] [Abstract][Full Text] [Related]
13. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
Honkanen J; Skarsvik S; Knip M; Vaarala O
Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
15. No extreme genetic risk for type 1 diabetes among DR3/4-DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband.
Eerligh P; Koeleman BP; Lie BA; Roep BO; Thorsby E
Tissue Antigens; 2011 Apr; 77(4):338-40. PubMed ID: 21388358
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
17. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
[TBL] [Abstract][Full Text] [Related]
18. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.
Pani MA; Van Autreve J; Van der Auwera BJ; Gorus FK; Badenhoop K
Diabetologia; 2002 Sep; 45(9):1340-3. PubMed ID: 12242468
[TBL] [Abstract][Full Text] [Related]
19. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
20. Impaired interleukin (IL)-4-associated generation of CCR4-expressing T cells in neonates with hereditary allergy risk.
Haddeland U; Sletten GB; Brandtzaeg P; Nakstad B
Clin Exp Immunol; 2005 Feb; 139(2):314-22. PubMed ID: 15654830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
